EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Repurposing Prescription Medications for Alzheimer's Disease Treatment: Mechanisms, Evidence, and Clinical Implications, a Narrative Review

Natasha Elaine Hastings

Innovative Research in Applied, Biological and Chemical Sciences · 2025

DOI: 10.62497/irabcs.182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innovative Research in Applied, Biological and Chemical Sciences, 2025. Verfasst von Natasha Elaine Hastings. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the most common cause of dementia worldwide, with prevalence growing alongside life expectancy. The burden of disease on healthcare systems globally is on the rise, as current treatments have failed to mitigate its morbidity, and this remains a dire public health concern. AD is characterized by the hallmarks of β-amyloid plaque deposition and neurofibrillary tangles of hyperphosphorylated tau proteins. Clinical diagnosis relies on clinical presentation and a series of testable criteria. Current treatments primarily focus on symptom management, while trials are underway to develop pharmaceuticals that may reduce the production of amyloid plaques and tau proteins. Alternatives include the repurposing of drugs already on market for treatment of other diseases such as diabetes, hypertension, inflammation, depression, epilepsy, and hypercholesterolemia. Due to their approved use in the management of other diseases, already licensed compounds proceed through trials in a faster and more cost-effective manner than un-licensed compounds. The aim of this paper is to draw attention to already-licensed compounds currently on the market that may prove effective in treating Alzheimer’s disease.

Zitieren

APA

Hastings, N. E. (2025). Repurposing Prescription Medications for Alzheimer's Disease Treatment: Mechanisms, Evidence, and Clinical Implications, a Narrative Review. Innovative Research in Applied, Biological and Chemical Sciences. https://doi.org/10.62497/irabcs.182

Vancouver

Hastings NE. Repurposing Prescription Medications for Alzheimer's Disease Treatment: Mechanisms, Evidence, and Clinical Implications, a Narrative Review. Innovative Research in Applied, Biological and Chemical Sciences. 2025. doi:10.62497/irabcs.182

BibTeX
@article{Hastings2025,
  author = {Hastings, Natasha Elaine},
  title = {Repurposing Prescription Medications for Alzheimer's Disease Treatment: Mechanisms, Evidence, and Clinical Implications, a Narrative Review},
  journal = {Innovative Research in Applied, Biological and Chemical Sciences},
  year = {2025},
  doi = {10.62497/irabcs.182}
}
Kostenlos starten →